Vivos Therapeutics, Inc. Investing Cash Flow
Vivos Therapeutics, Inc. (VVOS) reported Investing Cash Flow of -$434.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-14
- Vivos Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$416.00K.
- Vivos Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$18.00K.
- Vivos Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$1.58M.
- Vivos Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $83.00K.
- Vivos Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$7.53M.
- Vivos Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$568.00K.
- Vivos Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$853.00K.
- Vivos Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$924.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$416.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$434.00K 10-Q · filed 2026-08-14 | -$2.02M derived: sum of 3 quarters · filed 2026-08-14 | -$1.93M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | -$18.00K 10-Q · filed 2026-05-20 | -$1.60M derived: sum of 2 quarters · filed 2026-05-20 | -$1.52M derived: sum of 3 quarters · filed 2026-05-20 | -$7.42M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | -$1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$1.50M derived: sum of 2 quarters · filed 2026-04-15 | -$7.40M derived: sum of 3 quarters · filed 2026-08-14 | -$7.53M 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | $83.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$5.82M derived: sum of 2 quarters · filed 2026-08-14 | -$5.95M 10-Q · filed 2025-11-19 | -$6.11M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | -$5.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$6.03M 10-Q · filed 2026-08-14 | -$6.19M derived: sum of 3 quarters · filed 2026-08-14 | -$6.38M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | -$122.00K 10-Q · filed 2026-05-20 | -$287.00K derived: sum of 2 quarters · filed 2026-05-20 | -$479.00K derived: sum of 3 quarters · filed 2026-05-20 | -$539.00K derived: sum of 4 quarters · filed 2026-05-20 | ||||
| 2024-12-31 | -$165.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$357.00K derived: sum of 2 quarters · filed 2026-04-15 | -$417.00K derived: sum of 3 quarters · filed 2026-04-15 | -$568.00K 10-K · filed 2026-04-15 | ||||
| 2024-09-30 | -$192.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$252.00K derived: sum of 2 quarters · filed 2025-11-19 | -$403.00K 10-Q · filed 2025-11-19 | -$568.00K derived: sum of 4 quarters · filed 2025-11-19 | ||||
| 2024-06-30 | -$60.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | -$211.00K 10-Q · filed 2025-08-19 | -$376.00K derived: sum of 3 quarters · filed 2025-08-19 | -$530.00K derived: sum of 4 quarters · filed 2025-08-19 | ||||
| 2024-03-31 | -$151.00K 10-Q · filed 2025-05-15 | -$316.00K derived: sum of 2 quarters · filed 2025-05-15 | -$470.00K derived: sum of 3 quarters · filed 2025-05-15 | -$715.00K derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | -$165.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$319.00K derived: sum of 2 quarters · filed 2025-03-31 | -$564.00K derived: sum of 3 quarters · filed 2025-03-31 | -$853.00K 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$154.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$399.00K derived: sum of 2 quarters · filed 2024-11-14 | -$688.00K 10-Q · filed 2024-11-14 | -$888.00K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$245.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$534.00K 10-Q · filed 2024-08-14 | -$734.00K derived: sum of 3 quarters · filed 2024-08-14 | -$834.00K derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | -$289.00K 10-Q · filed 2024-05-14 | -$489.00K derived: sum of 2 quarters · filed 2024-07-30 | -$589.00K derived: sum of 3 quarters · filed 2024-07-30 | -$1.09M derived: sum of 4 quarters · filed 2024-07-30 | ||||
| 2022-12-31 | -$200.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-07-30 | -$300.00K derived: sum of 2 quarters · filed 2024-07-30 | -$804.00K derived: sum of 3 quarters · filed 2024-07-30 | -$924.00K 10-K/A · filed 2024-07-30 | ||||
| 2022-09-30 | -$100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$604.00K derived: sum of 2 quarters · filed 2023-11-14 | -$724.00K 10-Q · filed 2023-11-14 | -$1.11M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$504.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-16 | -$624.00K 10-Q · filed 2023-08-16 | -$1.01M derived: sum of 3 quarters · filed 2023-08-16 | -$1.44M derived: sum of 4 quarters · filed 2023-08-16 | ||||
| 2022-03-31 | -$120.00K 10-Q · filed 2023-06-08 | -$502.00K derived: sum of 2 quarters · filed 2023-06-08 | -$934.00K derived: sum of 3 quarters · filed 2023-06-08 | -$2.47M derived: sum of 4 quarters · filed 2023-06-08 | ||||
| 2021-12-31 | -$382.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$814.00K derived: sum of 2 quarters · filed 2023-03-30 | -$2.35M derived: sum of 3 quarters · filed 2023-03-30 | -$2.61M 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | -$432.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-12-20 | -$1.96M derived: sum of 2 quarters · filed 2022-12-20 | -$2.23M 10-Q · filed 2022-12-20 | -$2.23M 10-Q · filed 2021-11-15 | -$2.32M derived: sum of 4 quarters · filed 2022-12-20 | |||
| 2021-06-30 | -$1.53M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2022-12-20 | -$1.79M 10-Q · filed 2022-12-20 | -$1.79M 10-Q · filed 2021-08-12 | -$1.89M derived: sum of 3 quarters · filed 2022-12-20 | -$1.90M derived: sum of 4 quarters · filed 2022-12-20 | |||
| 2021-03-31 | -$262.00K 10-Q/A · filed 2022-11-25 | -$261.70K 10-Q · filed 2021-05-17 | -$356.99K derived: sum of 2 quarters · filed 2022-11-25 | -$368.99K derived: sum of 3 quarters · filed 2022-11-25 | -$376.80K derived: sum of 4 quarters · filed 2022-11-25 | |||
| 2020-12-31 | -$94.99K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$106.99K derived: sum of 2 quarters · filed 2022-03-31 | -$114.80K derived: sum of 3 quarters · filed 2022-03-31 | -$120.00K 10-K · filed 2022-03-31 | -$120.25K 10-K · filed 2021-03-25 | |||
| 2020-09-30 | -$12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$19.81K derived: sum of 2 quarters · filed 2021-11-15 | -$25.01K 10-Q · filed 2021-11-15 | |||||
| 2020-06-30 | -$7.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$13.01K 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | -$5.20K 10-Q · filed 2021-05-17 | |||||||
| 2019-12-31 | $86.22K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |